Insufferable former Citrin Cooperman client Martin Shkreli is no longer behind bars. From the Wall Street Journal:
Martin Shkreli, the so-called “pharma bro” who was widely criticized for raising the price of a lifesaving AIDS drug, has been released from federal prison.
Mr. Shkreli departed the Federal Correctional Institution Allenwood Low on Wednesday, according to the Federal Bureau of Prisons. Benjamin Brafman, a lawyer for Mr. Shkreli, said he has been transferred to a halfway house after completing programs that allowed for his prison sentence to be shortened.
A jury convicted Mr. Shkreli in 2017 on federal securities-fraud charges involving two hedge funds he managed and a company he founded. He was originally sentenced to serve seven years in prison.
Vyera Pharmaceuticals LLC, which Mr. Shkreli ran as chief executive when it was called Turing Pharmaceuticals AG, purchased exclusive rights to antiparasitic drug Daraprim for $55 million in 2015 and raised its price to $750 a tablet from $17.50 a tablet, according to court documents. The company also blocked competitors from making generic versions. The price hike was widely condemned at the time.
According to the Federal Bureau of Prisons, Shkreli is scheduled to be released from federal custody on Sept. 14.
‘Pharma Bro’ Martin Shkreli Released From Prison Early [Wall Street Journal]
Photo credit: Dennis Van Tine/Alamy Stock Photo